Company Filing History:
2 out of 541 
1 out of 153 Years Active: 2011-2012
Title: Jane Tian: Innovator in High Affinity Antibodies
Introduction
Jane Tian is a prominent inventor based in North Potomac, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of high affinity antibodies. With a total of 2 patents, her work focuses on therapeutic applications for inflammatory diseases.
Latest Patents
Jane Tian's latest patents include innovative compositions and methods for inhibiting the release of proinflammatory cytokines from vertebrate cells. These high affinity antibodies specifically bind to HMGB1 and its antigenic fragments. The therapeutic potential of these antibodies extends to a wide range of inflammatory diseases and disorders, including sepsis, rheumatoid arthritis, Crohn's disease, and more. Additionally, these antibodies serve as diagnostic tools, enhancing the understanding and treatment of various inflammatory conditions.
Career Highlights
Throughout her career, Jane has worked with notable organizations such as MedImmune Limited and The Feinstein Institute for Medical Research. Her experience in these institutions has allowed her to advance her research and contribute to significant medical innovations.
Collaborations
Jane Tian has collaborated with esteemed colleagues, including Herren Wu and Changshou Gao. These partnerships have further enriched her research and development efforts in the field of biotechnology.
Conclusion
Jane Tian's innovative work in high affinity antibodies showcases her dedication to advancing medical science. Her contributions have the potential to impact the treatment of various inflammatory diseases significantly.